Thalidomide-O-C4-COOH
≥95%
- Product Code: 106493
CAS:
2169266-67-3
| Molecular Weight: | 374.34 g./mol | Molecular Formula: | C₁₈H₁₈N₂O₇ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, dry, sealed |
Product Description:
Thalidomide-O-C4-COOH is primarily utilized in research and development within the pharmaceutical industry, particularly in the study of targeted drug delivery systems. Its structure allows it to act as a linker or conjugate in the design of prodrugs, enabling the attachment of therapeutic agents to enhance their specificity and efficacy. This compound is often explored in the context of cancer therapy, where it can be used to modify the pharmacokinetics and biodistribution of anticancer drugs, potentially reducing off-target effects and improving treatment outcomes. Additionally, it is investigated for its role in immunomodulation, particularly in conditions where selective inhibition of inflammatory pathways is required. Researchers also study its potential in creating more stable and bioavailable drug formulations, contributing to advancements in personalized medicine.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | $2,576.59 |
+
-
|
Thalidomide-O-C4-COOH
Thalidomide-O-C4-COOH is primarily utilized in research and development within the pharmaceutical industry, particularly in the study of targeted drug delivery systems. Its structure allows it to act as a linker or conjugate in the design of prodrugs, enabling the attachment of therapeutic agents to enhance their specificity and efficacy. This compound is often explored in the context of cancer therapy, where it can be used to modify the pharmacokinetics and biodistribution of anticancer drugs, potentially reducing off-target effects and improving treatment outcomes. Additionally, it is investigated for its role in immunomodulation, particularly in conditions where selective inhibition of inflammatory pathways is required. Researchers also study its potential in creating more stable and bioavailable drug formulations, contributing to advancements in personalized medicine.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :